How to Get Cialis (Tadalafil) in Maryland: Telehealth, Prescriptions, and Pharmacy Options

Prescription access and medication affordability image for How to Get Cialis (Tadalafil) in Maryland: Telehealth, Prescriptions, and Pharmacy Options

How to Get Cialis (Tadalafil) in Maryland

At a glance

  • Generic name / tadalafil (Cialis), FDA-approved for ED and BPH
  • Prescription status / prescription-only in Maryland (Schedule: non-controlled)
  • Dosing options / daily 2.5 to 5 mg or on-demand 10 to 20 mg oral tablet
  • Telehealth prescribing / fully legal in Maryland with an established provider-patient relationship
  • Prescribing authority / MDs, DOs, NPs (with CRNP certification), and PAs can prescribe
  • 503A compounding / permitted in Maryland under state Board of Pharmacy oversight
  • Maryland Medicaid / covers tadalafil for ED and BPH with prior authorization
  • Manufacturer / Eli Lilly (brand Cialis); multiple generic manufacturers available
  • Patent status / tadalafil patent expired September 2018; generics widely available
  • Typical delivery timeline / 2 to 5 business days via telehealth pharmacy fulfillment

Tadalafil Prescribing Is Legal Through Maryland Telehealth

Maryland fully authorizes telehealth prescribing for tadalafil. The Maryland Board of Physicians permits synchronous video or audio consultations to establish a provider-patient relationship, which satisfies the state requirement for issuing a prescription. No in-person visit is mandatory for this non-controlled medication.

The clinical foundation for tadalafil rests on large randomized controlled trials. Brock et al. published a key integrated analysis of 11 placebo-controlled trials (N=1,112 on tadalafil) in the Journal of Urology, reporting that tadalafil 20 mg improved erectile function domain scores by a mean of 7.9 points on the International Index of Erectile Function (IIEF) versus 1.8 points for placebo (P<0.001) [1]. That magnitude of benefit is why the American Urological Association (AUA) guidelines list PDE5 inhibitors as first-line pharmacotherapy for ED [2].

Maryland-licensed telehealth providers typically conduct a structured intake covering cardiovascular risk stratification, current medications (with specific attention to nitrate use), and symptom severity scoring. The visit itself takes 10 to 20 minutes. Once the clinician confirms that tadalafil is appropriate, the prescription is transmitted electronically to a pharmacy of the patient's choice, including mail-order and 503A compounding pharmacies.

A 2021 JAMA Network Open study found that telehealth visits for men's health conditions increased by 154% during 2020, with ED representing the most common diagnosis in that category [3]. Maryland's regulatory framework accommodated this growth without requiring emergency waivers, because existing statute already permitted synchronous telehealth prescribing for non-controlled substances.

Who Can Prescribe Cialis in Maryland

Three categories of licensed providers in Maryland hold prescriptive authority for tadalafil: physicians (MDs and DOs), certified registered nurse practitioners (CRNPs), and physician assistants (PAs). Each operates under distinct regulatory oversight, but all three can independently evaluate, diagnose, and prescribe for erectile dysfunction or BPH.

CRNPs in Maryland practice under an attestation agreement rather than a supervisory model. Since 2015, Maryland law has granted CRNPs full practice authority after completing a transition-to-practice period. This means a CRNP can prescribe tadalafil without a physician co-signature. PAs prescribe under a delegation agreement with a supervising physician, though the physician does not need to be physically present for each prescription.

The AUA's 2018 guideline update states: "Phosphodiesterase type 5 inhibitors should be offered as first-line therapy to men with erectile dysfunction who are candidates for pharmacotherapy" [2]. Any of the three provider types listed above can apply this recommendation. If a patient has complex cardiovascular disease, unstable angina, or recent stroke (within 6 months), Maryland providers of all credential levels are expected to refer for cardiology clearance before prescribing, per the Princeton III Consensus recommendations [4].

Daily vs. On-Demand Dosing: Choosing the Right Protocol

Tadalafil is available in two distinct dosing regimens. Daily dosing (2.5 mg or 5 mg taken once every 24 hours) provides continuous drug levels and allows spontaneous sexual activity without timing a dose. On-demand dosing (10 mg or 20 mg taken at least 30 minutes before anticipated sexual activity) is used as needed, with a maximum frequency of once per 24 hours.

The choice depends on frequency of sexual activity and whether the patient also has BPH. The FDA-approved prescribing information specifies that daily 5 mg tadalafil is the only PDE5 inhibitor regimen simultaneously approved for both ED and BPH-related lower urinary tract symptoms (LUTS) [5]. In a 12-week trial of men with both conditions, daily tadalafil 5 mg improved total International Prostate Symptom Score (IPSS) by 4.7 points versus 2.3 for placebo, while also improving IIEF-EF domain scores [6].

For patients having intercourse two or more times per week, daily dosing often proves more convenient and cost-effective with generic pricing. Patients who are sexually active once a week or less frequently may prefer on-demand dosing. Tadalafil's 17.5-hour half-life, the longest among approved PDE5 inhibitors, gives on-demand users a wider activity window compared to sildenafil (half-life: 3 to 5 hours) or vardenafil (half-life: 4 to 5 hours) [5].

Labs and Screening Before Starting Tadalafil in Maryland

Maryland providers ordering tadalafil for the first time should confirm baseline cardiovascular safety and identify reversible causes of ED. There is no mandatory state lab panel for tadalafil prescribing, but clinical guidelines recommend the following baseline assessments.

A fasting lipid panel and fasting glucose (or HbA1c) are standard because ED shares risk factors with cardiovascular disease. The Endocrine Society's 2018 clinical practice guideline recommends measuring morning total testosterone in men presenting with ED, since testosterone deficiency is identified in approximately 12% to 20% of men over age 45 with erectile complaints [7]. Dr. Shalender Bhasin, principal author of the Endocrine Society guideline, has written: "A morning total testosterone level should be obtained in all men with erectile dysfunction to exclude hypogonadism as a contributing or primary cause" [7].

Blood pressure measurement is required. Tadalafil produces a mean reduction of 1 to 2 mmHg in systolic blood pressure, which is clinically insignificant in most patients but can be dangerous when combined with nitrates or alpha-blockers at non-stable doses [5]. Providers also screen for concurrent nitrate use (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate), which is an absolute contraindication.

A basic metabolic panel is reasonable but not strictly required. If the patient's medical history and physical exam suggest no renal or hepatic impairment and no cardiovascular instability, some telehealth providers will prescribe based on a thorough history alone. The AUA guideline does not mandate laboratory testing before PDE5 inhibitor initiation in otherwise healthy men with straightforward ED presentations [2].

Maryland Medicaid and Insurance Coverage for Tadalafil

Maryland Medicaid covers tadalafil for both ED and BPH indications, but requires prior authorization (PA). The PA process confirms medical necessity and verifies that the patient has tried lifestyle modification or that the diagnosis is documented with appropriate clinical criteria.

Generic tadalafil has significantly reduced out-of-pocket costs since patent expiration in September 2018. A 30-day supply of daily tadalafil 5 mg through a retail pharmacy in Maryland typically costs between $15 and $60 with a GoodRx-type discount coupon, depending on the pharmacy. Brand Cialis remains priced at approximately $400 to $500 for 30 tablets without insurance, making generics the practical choice for most patients.

Commercial insurance plans in Maryland vary widely. Some formularies place generic tadalafil on Tier 2 (preferred generic) with copays of $10 to $25. Others classify it as Tier 3 (non-preferred) or exclude ED medications entirely. The Maryland Insurance Administration does not mandate that commercial plans cover ED pharmacotherapy, so coverage is plan-specific.

For patients whose insurance denies coverage, 503A compounding pharmacies offer an alternative. Compounded tadalafil capsules or troches can be dispensed at lower per-dose costs, though they are not AB-rated generics and are not interchangeable with FDA-approved products at the pharmacy level. The patient must have a prescription specifically written for compounded tadalafil.

503A Compounding Pharmacies in Maryland

Maryland's Board of Pharmacy licenses 503A compounding pharmacies to prepare patient-specific compounded medications, including tadalafil, when a valid prescription exists. These pharmacies operate under both state and federal law (Section 503A of the Federal Food, Drug, and Cosmetic Act) and may ship compounded prescriptions directly to Maryland patients.

A 503A pharmacy prepares each prescription for an individual patient based on a prescriber's order. This differs from 503B outsourcing facilities, which produce larger batches without patient-specific prescriptions. In Maryland, 503A pharmacies must comply with USP <795> standards for non-sterile compounding.

Compounded tadalafil formulations may include sublingual troches, capsules, or combination products (such as tadalafil combined with oxytocin or PT-141). These combinations are not FDA-approved and should only be used under direct clinician supervision. The FDA's compounding page provides regulatory context for patients and prescribers evaluating compounded options [8].

When selecting a 503A pharmacy in Maryland, patients should verify that the pharmacy holds a current Maryland Board of Pharmacy license, uses third-party potency testing, and follows current good compounding practices. Telehealth platforms partnered with specific compounding pharmacies will handle fulfillment directly, with shipping timelines of 2 to 5 business days to most Maryland addresses.

Prior Authorization: What Maryland Patients Need to Know

When Maryland Medicaid or a commercial insurer requires prior authorization for tadalafil, the prescribing provider submits clinical documentation supporting medical necessity. The typical PA package includes the following elements.

A documented diagnosis of ED (ICD-10: N52.01 through N52.9) or BPH (ICD-10: N40.0 or N40.1) is the starting point. The insurer expects chart notes confirming symptom duration, severity (often quantified by IIEF-5 or Sexual Health Inventory for Men score), and impact on quality of life. For BPH, an IPSS score and documentation of bothersome LUTS are standard.

The PA form also asks whether the patient has tried and failed alternative therapies. For ED, this may include PDE5 inhibitor alternatives (sildenafil, vardenafil, avanafil), vacuum erection devices, or lifestyle interventions. For BPH, insurers may require documentation of a trial of an alpha-blocker (tamsulosin, alfuzosin) or 5-alpha reductase inhibitor (finasteride, dutasteride) before approving tadalafil 5 mg daily.

PA turnaround times in Maryland range from 24 to 72 hours for standard requests. Urgent or expedited reviews can be completed within 24 hours when the prescriber documents clinical urgency. If the PA is denied, the patient and provider may appeal through the insurer's internal process or, for Maryland Medicaid, through a fair hearing process administered by the Maryland Department of Health.

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins, has noted: "Prior authorization for PDE5 inhibitors creates unnecessary barriers for a condition that is both prevalent and treatable. In clinical practice, the delays associated with PA can discourage patients from following through on treatment" [9].

Transferring a Cialis Prescription to a Maryland Pharmacy

Patients relocating to Maryland or traveling within the state can transfer an existing tadalafil prescription from an out-of-state pharmacy. Maryland accepts prescription transfers for non-controlled medications under the Maryland Board of Pharmacy's transfer regulations. The receiving pharmacist contacts the originating pharmacy to verify the prescription details, remaining refills, and prescriber information.

The process takes 15 to 30 minutes in most cases. Patients should bring their current prescription bottle or have the originating pharmacy's name and phone number ready. If the original prescription has expired (older than 12 months in Maryland for non-controlled substances), a new prescription from a Maryland-licensed provider is required. Telehealth consultations can generate a new prescription within the same day if the prior medical records are available for review.

For patients using a compounded tadalafil product, transfer is more complex. Compounding prescriptions are pharmacy-specific; a new prescription may need to be written for the receiving 503A pharmacy's specific formulation. Coordinating with both the prescriber and the new pharmacy ensures no gap in treatment.

Timeline: From Consultation to Medication in Hand

Maryland residents using a telehealth platform can typically complete the full process, from initial consultation to receiving tadalafil, within 3 to 7 days. The breakdown is straightforward.

The telehealth consultation itself takes 10 to 20 minutes and can often be scheduled same-day or next-day. Prescription review and processing takes 1 to 2 business days. Shipping from either a retail mail-order pharmacy or a 503A compounding pharmacy adds 2 to 5 business days via standard ground shipping, with expedited options available for an additional fee.

Patients who visit an in-person prescriber and use a local retail pharmacy can fill generic tadalafil the same day in most cases. The 88,000+ retail pharmacies nationwide that stock generic tadalafil include all major Maryland chains: CVS, Walgreens, Rite Aid, Walmart, and independent pharmacies. Stock shortages for generic tadalafil are uncommon, though specific dosage strengths (particularly 2.5 mg tablets for daily use) may occasionally require a 1 to 2 day order at smaller pharmacies.

The FDA's Approved Drug Products with Therapeutic Equivalence Evaluations (the Orange Book) lists over 15 approved generic tadalafil manufacturers as of 2025, ensuring broad supply chain availability [10].

Frequently asked questions

How do I get a Cialis prescription in Maryland?
Schedule a visit with a Maryland-licensed physician, nurse practitioner, or physician assistant. Both in-person and telehealth (video or audio) consultations are legally permitted. The provider will evaluate your symptoms, review medications for contraindications (especially nitrates), and electronically transmit the prescription to your chosen pharmacy.
What labs are needed before Cialis in Maryland?
No Maryland-specific lab mandate exists. Clinical guidelines recommend a morning total testosterone level, fasting glucose or HbA1c, lipid panel, and blood pressure measurement. For otherwise healthy men with straightforward ED, some providers will prescribe based on a thorough history and medication review alone.
Are there telehealth providers in Maryland prescribing Cialis?
Yes. Maryland permits synchronous telehealth prescribing for non-controlled medications like tadalafil. Multiple platforms, including HealthRX, offer Maryland-licensed clinicians who can evaluate, diagnose, and prescribe tadalafil in a single virtual visit.
How long until I receive Cialis in Maryland?
Same-day pickup is possible at local retail pharmacies with an in-person visit. Telehealth-to-mail-order or compounding pharmacy fulfillment takes 3 to 7 days total: 1 to 2 days for prescription processing plus 2 to 5 days for shipping.
Can I transfer a Cialis prescription to Maryland?
Yes. Maryland pharmacies accept transfers of non-controlled prescriptions from out-of-state pharmacies. The receiving pharmacist verifies the prescription with the originating pharmacy. If the prescription is older than 12 months, a new one is required.
Are 503A pharmacies in Maryland licensed to ship tadalafil?
Yes. Maryland-licensed 503A compounding pharmacies can prepare and ship patient-specific compounded tadalafil with a valid prescription. They must comply with USP 795 standards and hold a current Maryland Board of Pharmacy license.
Who can prescribe Cialis in Maryland: MD vs NP vs PA?
All three can prescribe tadalafil. MDs and DOs prescribe independently. CRNPs (nurse practitioners) in Maryland have full practice authority after a transition period. PAs prescribe under a delegation agreement with a supervising physician.
What documentation does prior authorization require in Maryland?
PA submissions require a confirmed diagnosis (ICD-10 code for ED or BPH), symptom severity documentation (IIEF-5 or IPSS scores), medication history showing contraindications or failure of alternatives, and chart notes from the evaluating provider. Turnaround is typically 24 to 72 hours.
Is generic tadalafil available in Maryland?
Yes. Tadalafil's patent expired in September 2018. Over 15 generic manufacturers now produce FDA-approved tadalafil tablets in 2.5 mg, 5 mg, 10 mg, and 20 mg strengths, available at all major Maryland retail pharmacies.
What is the cost of generic tadalafil in Maryland without insurance?
A 30-day supply of daily tadalafil 5 mg typically costs $15 to $60 at Maryland retail pharmacies using a discount coupon. On-demand dosing (10 mg or 20 mg) costs vary based on quantity, ranging from $1 to $4 per tablet at most pharmacies.

References

  1. Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
  2. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018, amended 2022). J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/35536479/
  3. Khoong EC, Rivadeneira NA, Fontenot JC, et al. Assessing the use of telehealth for men's health conditions during COVID-19. JAMA Netw Open. 2021;4(5):e2110634. https://pubmed.ncbi.nlm.nih.gov/34042994/
  4. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/23040454/
  5. U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. Revised 2011. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20lbl.pdf
  6. Porst H, Kim ED, Casabé AR, et al. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial. Eur Urol. 2011;60(5):1105-1113. https://pubmed.ncbi.nlm.nih.gov/21871706/
  7. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  8. U.S. Food and Drug Administration. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding
  9. Burnett AL. Erectile dysfunction management and the role of PDE5 inhibitors in clinical practice. J Urol. 2020;204(5):876-877. https://pubmed.ncbi.nlm.nih.gov/32479754/
  10. U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm